A Real-World Phase IV Superiority Trial and Cost-Effectiveness Analysis of the Addition of Low-Dose Nivolumab to Triple Metronomic Chemotherapy Compared to the Paclitaxel Carboplatin Regimen in Recurrent or Metastatic Head and Neck Cancer Patients.
Saved in:
| Title: | A Real-World Phase IV Superiority Trial and Cost-Effectiveness Analysis of the Addition of Low-Dose Nivolumab to Triple Metronomic Chemotherapy Compared to the Paclitaxel Carboplatin Regimen in Recurrent or Metastatic Head and Neck Cancer Patients. |
|---|---|
| Authors: | Khadela A; Department of Pharmacology, LM. College of Pharmacy, Ahmedabad, Gujarat, India., Parikh R; Pharm. D Section, Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India., Vaghela J; Pharm. D Section, Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India., Chauhan Y; Pharm. D Section, Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India., Shah VB; Pharm. D Section, Department of Pharmacology, L. M. College of Pharmacy, Ahmedabad, Gujarat, India., Kothari R; Oncowin Cancer Centre, Ahmedabad, Gujarat, India., Merja M; Sterling Hospital, Ahmedabad, Gujarat, India. |
| Source: | Head & neck [Head Neck] 2026 Mar; Vol. 48 (3), pp. 765-773. Date of Electronic Publication: 2025 Oct 17. |
| Publication Type: | Journal Article; Clinical Trial, Phase IV; Comparative Study |
| Journal Info: | Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1097-0347 |
|---|---|
| DOI: | 10.1002/hed.70077 |
